InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,954.40
(
-0.17%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.93
(
0.46%
)
Bitcoin
57,352.19
(
-1.52%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12424
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Monday, 11/29/2010 8:17:39 AM

Monday, November 29, 2010 8:17:39 AM

Post# of 80490
Examples of what happens to the share price with a little revenue in biotech land. That's why approval of Rida could really be decisive for the SP.

INCY, which is in the oncology field, has $90 million in sales, and a $2 billion market cap.

VRTX, which is more mature and not in ocology, has $111 in sales and a $7 billion market cap.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up